Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.21), $0.09 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $9.5 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.